<DOC>
	<DOCNO>NCT02421107</DOCNO>
	<brief_summary>The company develop GlySure product previously carry study able show GlySure system accurate measure blood sugar ( glucose ) level . This do patient intensive care unit ( ICU ) heart surgery . The company want confirm GlySure product accurate measure blood glucose level patient stay ICU . This clinical study require 40 patient check safety continuous Glucose Monitoring System ( GlySure ) 's performance comparison separate individual blood glucose test use hand hold blood tester call i-STAT . Each patient must study least 36 hour . The main benefit continuous blood glucose monitoring give true picture glucose status patient potentially help avoid glucose level drop low ( hypoglycaemic ) stay high ( hyperglycaemia ) clinicians intervene base ` real-time ` data glucose level . In study patient treatment dictate data measure study . Clinicians blind result GlySure monitor .</brief_summary>
	<brief_title>GlySure Acute Care Settings Study</brief_title>
	<detailed_description />
	<criteria>1 . Patient legal representative MUST willing sign inform consent document 2 . Patient male female age 18 year 3 . Patient require Central Venous Catheter ( CVC ) insert part disease management treatment 4 . Patient expect remain intensive care unit least 36 hour post enrolment study 1 . Patient legal representative unable provide write informed consent 2 . Patient pregnant 3 . Patient currently administer Mannitol and/or may require administration Mannitol whilst ICU 4 . Patient history pulmonary embolism ( PE ) 5 . Patient history thrombosis 6 . Patient known hypercoagulation 7 . Patient known history heparin hypersensitivity 8 . Patient history heparin induce thrombocytopenia 9 . Participation clinical study involve unlicensed pharmaceutical product device within 3 month prior enrolment study 10 . Patient known hypersensitivity/allergy adhesive I.V . dressing 3M Tegaderm film StatLockÂ® device 11 . Patient manage cardiac ICU set cardiac surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>